olaparib targets prostate cancer mutations Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer. Phosphate-binder therapy does not reduce mortality ...

April 29, 2010 (Orlando, Florida) — Taking a proton pump inhibitor (PPI) with a phosphate binder might improve phosphorus control in patients on hemodialysis, according to a retrospective study ...

Please provide your email address to receive an email when new articles are posted on . Data released from the Dialysis Outcomes and Practice Patterns Study Program show use of the calcimimetic ...

Newark, NJ, May 30, 2022 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, The global feed binder market is expected to grow from USD 5.10 billion in 2019 to USD 6.58 billion by 2027, ...

The medication may represent a new treatment option for dialysis patients, researchers concluded. A team led by Rong Wang, MD, of Shandong Provincial Hospital in Shandong, China, analyzed 8 randomized ...